137 related articles for article (PubMed ID: 24076366)
1. A new class of aggregation inhibitor of amyloid-β peptide based on an O-acyl isopeptide.
Kawashima H; Sohma Y; Nakanishi T; Kitamura H; Mukai H; Yamashita M; Akaji K; Kiso Y
Bioorg Med Chem; 2013 Nov; 21(21):6323-7. PubMed ID: 24076366
[TBL] [Abstract][Full Text] [Related]
2. The 'O-acyl isopeptide method' for the synthesis of difficult sequence-containing peptides: application to the synthesis of Alzheimer's disease-related amyloid beta peptide (Abeta) 1-42.
Sohma Y; Hayashi Y; Kimura M; Chiyomori Y; Taniguchi A; Sasaki M; Kimura T; Kiso Y
J Pept Sci; 2005 Jul; 11(8):441-51. PubMed ID: 15761877
[TBL] [Abstract][Full Text] [Related]
3. Medicinal Chemistry Focusing on Aggregation of Amyloid-β.
Sohma Y
Chem Pharm Bull (Tokyo); 2016; 64(1):1-7. PubMed ID: 26726739
[TBL] [Abstract][Full Text] [Related]
4. "Click peptides"--chemical biology-oriented synthesis of Alzheimer's disease-related amyloid beta peptide (abeta) analogues based on the "O-acyl isopeptide method".
Sohma Y; Kiso Y
Chembiochem; 2006 Oct; 7(10):1549-57. PubMed ID: 16915597
[TBL] [Abstract][Full Text] [Related]
5. 'Click peptide' using production of monomer Aβ from the O-acyl isopeptide: application to assay system of aggregation inhibitors and cellular cytotoxicity.
Sohma Y; Hirayama Y; Taniguchi A; Mukai H; Kiso Y
Bioorg Med Chem; 2011 Mar; 19(5):1729-33. PubMed ID: 21330139
[TBL] [Abstract][Full Text] [Related]
6. Development of O-acyl isopeptide method.
Sohma Y; Yoshiya T; Taniguchi A; Kimura T; Hayashi Y; Kiso Y
Biopolymers; 2007; 88(2):253-62. PubMed ID: 17236207
[TBL] [Abstract][Full Text] [Related]
7. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
[TBL] [Abstract][Full Text] [Related]
10. Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry.
Fiori J; Naldi M; Bartolini M; Andrisano V
Electrophoresis; 2012 Nov; 33(22):3380-6. PubMed ID: 22961751
[TBL] [Abstract][Full Text] [Related]
11. Self-assembly pathways of E22Δ-type amyloid β peptide mutants generated from non-aggregative O-acyl isopeptide precursors.
Sohma Y; Wang H; Taniguchi A; Hirayama Y; Kakizawa T; Yamasaki M; Mukai H; Kiso Y
Bioorg Med Chem; 2011 Jun; 19(12):3787-92. PubMed ID: 21612934
[TBL] [Abstract][Full Text] [Related]
12. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
Matharu B; El-Agnaf O; Razvi A; Austen BM
Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
[TBL] [Abstract][Full Text] [Related]
13. Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach.
Bartolini M; Naldi M; Fiori J; Valle F; Biscarini F; Nicolau DV; Andrisano V
Anal Biochem; 2011 Jul; 414(2):215-25. PubMed ID: 21435333
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of β-amyloid peptide self-assembly and cytotoxicity by poly(LVFF-co-β-amino ester).
Xie H; Qiao Z; Wang H; Duan H; Yang Y; Wang C
J Pept Sci; 2015 Jul; 21(7):608-14. PubMed ID: 25931322
[TBL] [Abstract][Full Text] [Related]
15. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
[TBL] [Abstract][Full Text] [Related]
16. "Click peptide" based on the "o-acyl isopeptide method": control of A beta1-42 production from a photo-triggered A beta1-42 analogue.
Taniguchi A; Sohma Y; Kimura M; Okada T; Ikeda K; Hayashi Y; Kimura T; Hirota S; Matsuzaki K; Kiso Y
J Am Chem Soc; 2006 Jan; 128(3):696-7. PubMed ID: 16417340
[TBL] [Abstract][Full Text] [Related]
17. Strong inhibition of beta-amyloid peptide aggregation realized by two-steps evolved peptides.
Ghimire Gautam S; Komatsu M; Nishigaki K
Chem Biol Drug Des; 2015 Mar; 85(3):356-68. PubMed ID: 25082146
[TBL] [Abstract][Full Text] [Related]
18. Engineered polymer nanoparticles containing hydrophobic dipeptide for inhibition of amyloid-β fibrillation.
Skaat H; Chen R; Grinberg I; Margel S
Biomacromolecules; 2012 Sep; 13(9):2662-70. PubMed ID: 22897679
[TBL] [Abstract][Full Text] [Related]
19. In vitro amyloid-β binding and inhibition of amyloid-β self-association by therapeutic albumin.
Milojevic J; Costa M; Ortiz AM; Jorquera JI; Melacini G
J Alzheimers Dis; 2014; 38(4):753-65. PubMed ID: 24072068
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
